PURPOSE: The purpose of this study was to quantify the relationship of bone marrow response to radiation dose, using 3'-deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT)-labeled uptake quantified in positron-emission tomography (PET) scans. METHODS AND MATERIALS: Pre- and post-Week 1 treatment [(18)F]FLT PET images were registered to the CT images used to create the radiation treatment plan. Changes in [(18)F]FLT uptake values were measured using profile data of standardized uptake values (SUVs) and doses along the vertebral bodies located at a field border where a range of radiation doses were present for 10 patients. Data from the profile measurements were grouped into 1 Gy dose bins from 1 to 9 Gy to compare SUV changes for all patients. Additionally, the maximum pretreatment, the post-Week 1 treatment, and the dose values located within the C6-T7 vertebrae that straddled the field edge were measured for all patients. RESULTS: Both the profile and the individual vertebral data showed a strong correlation between SUV change and radiation dose. Relative differences in SUVs between bins >1 Gy and <7 Gy were statistically significant (p < 0.01, two-sample t test). The reduction in SUV was approximately linear until it reached a reduction threshold of 75%-80% in SUV for doses greater than 6 Gy/week for both the dose-binned data and the vertebral maximum SUVs. CONCLUSIONS: The change in SUV observed in head and neck cancer patients treated with chemoradiation shows the potential for using [(18)F]FLT PET images for identifying active bone marrow and monitoring changes due to radiation dose. Additionally, the change in [(18)F]FLT uptake observed in bone marrow for different weekly doses suggests potential dose thresholds for reducing bone marrow toxicity.
PURPOSE: The purpose of this study was to quantify the relationship of bone marrow response to radiation dose, using 3'-deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT)-labeled uptake quantified in positron-emission tomography (PET) scans. METHODS AND MATERIALS: Pre- and post-Week 1 treatment [(18)F]FLT PET images were registered to the CT images used to create the radiation treatment plan. Changes in [(18)F]FLT uptake values were measured using profile data of standardized uptake values (SUVs) and doses along the vertebral bodies located at a field border where a range of radiation doses were present for 10 patients. Data from the profile measurements were grouped into 1 Gy dose bins from 1 to 9 Gy to compare SUV changes for all patients. Additionally, the maximum pretreatment, the post-Week 1 treatment, and the dose values located within the C6-T7 vertebrae that straddled the field edge were measured for all patients. RESULTS: Both the profile and the individual vertebral data showed a strong correlation between SUV change and radiation dose. Relative differences in SUVs between bins >1 Gy and <7 Gy were statistically significant (p < 0.01, two-sample t test). The reduction in SUV was approximately linear until it reached a reduction threshold of 75%-80% in SUV for doses greater than 6 Gy/week for both the dose-binned data and the vertebral maximum SUVs. CONCLUSIONS: The change in SUV observed in head and neck cancerpatients treated with chemoradiation shows the potential for using [(18)F]FLT PET images for identifying active bone marrow and monitoring changes due to radiation dose. Additionally, the change in [(18)F]FLT uptake observed in bone marrow for different weekly doses suggests potential dose thresholds for reducing bone marrow toxicity.
Authors: Kevin Albuquerque; David Giangreco; Courtney Morrison; Mohammed Siddiqui; Jim Sinacore; Ronald Potkul; John Roeske Journal: Int J Radiat Oncol Biol Phys Date: 2010-05-12 Impact factor: 7.038
Authors: Clark J Brixey; John C Roeske; Anthony E Lujan; S Diane Yamada; Jacob Rotmensch; Arno J Mundt Journal: Int J Radiat Oncol Biol Phys Date: 2002-12-01 Impact factor: 7.038
Authors: Andreas K Buck; Gisela Halter; Holger Schirrmeister; Jörg Kotzerke; Imke Wurziger; Gerhard Glatting; Torsten Mattfeldt; Bernd Neumaier; Sven N Reske; Martin Hetzel Journal: J Nucl Med Date: 2003-09 Impact factor: 10.057
Authors: Hubert Vesselle; John Grierson; Lanell M Peterson; Mark Muzi; David A Mankoff; Kenneth A Krohn Journal: J Nucl Med Date: 2003-09 Impact factor: 10.057
Authors: Helmut Dittmann; Bernhard Matthias Dohmen; Frank Paulsen; Kai Eichhorn; Susanne Martina Eschmann; Marius Horger; Manfred Wehrmann; Hans Juergen Machulla; Roland Bares Journal: Eur J Nucl Med Mol Imaging Date: 2003-07-26 Impact factor: 9.236
Authors: David C P Cobben; Bernard F A M van der Laan; Bram Maas; Willem Vaalburg; Albert J H Suurmeijer; Harald J Hoekstra; Pieter L Jager; Philip H Elsinga Journal: J Nucl Med Date: 2004-02 Impact factor: 10.057
Authors: Anthony E Lujan; Arno J Mundt; S Diane Yamada; Jacob Rotmensch; John C Roeske Journal: Int J Radiat Oncol Biol Phys Date: 2003-10-01 Impact factor: 7.038
Authors: Eric Dinges; Nicole Felderman; Sarah McGuire; Brandie Gross; Sudershan Bhatia; Sarah Mott; John Buatti; Dongxu Wang Journal: Radiother Oncol Date: 2015-05-13 Impact factor: 6.280
Authors: Laura L Boles Ponto; Susan Walsh; Jiangeng Huang; Christine Mundt; Katherine Thede-Reynolds; G Leonard Watkins; John Sunderland; Michael Acevedo; Maureen Donovan Journal: AAPS J Date: 2017-12-07 Impact factor: 4.009
Authors: Christian L Barney; Nicholas Scoville; Eric Allan; Ahmet Ayan; Dominic DiCostanzo; Karl E Haglund; John Grecula; Terence Williams; Meng Xu-Welliver; Gregory A Otterson; Jose G Bazan Journal: Int J Radiat Oncol Biol Phys Date: 2017-11-23 Impact factor: 7.038
Authors: Sarah M McGuire; Sudershan K Bhatia; Wenqing Sun; Geraldine M Jacobson; Yusuf Menda; Laura L Ponto; Brian J Smith; Brandie A Gross; John E Bayouth; John J Sunderland; Michael M Graham; John M Buatti Journal: Int J Radiat Oncol Biol Phys Date: 2016-04-19 Impact factor: 7.038
Authors: Joshua A Rowe; Federica Morandi; Dustin R Osborne; Jonathan S Wall; Stephen J Kennel; Robert B Reed; Amy K LeBlanc Journal: Anat Histol Embryol Date: 2018-10-23 Impact factor: 1.114